Trials / Sponsors / Institute of Hematology and Blood Transfusion, Czech Republic
Institute of Hematology and Blood Transfusion, Czech Republic
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML, Proton Therapy | Phase 1 / Phase 2 | 2025-11-21 |
| Recruiting | CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial Leukemia, Myeloid, Acute(AML), Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic Syndromes (MDS) | EARLY_Phase 1 | 2024-10-23 |
| Recruiting | CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Ly Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed | Phase 1 | 2021-06-02 |
| Terminated | Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed | Phase 2 | 2021-02-16 |
| Completed | Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed | Phase 2 | 2019-05-09 |